Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop
tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well ixabepilone works in treating patients with
metastatic germ cell tumors that are refractory to cisplatin.